Copyright
©The Author(s) 2019.
World J Diabetes. Mar 15, 2019; 10(3): 181-188
Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.181
Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.181
Table 3 Association between the variant IVS6+31 C>T investigated in RFX6 gene and type 2 diabetes risk
| Control, n (%) | T2D, n (%) | P-value | OR | 95%CI | |
| genotype | |||||
| C \ C | 130 (91.5) | 128 (90.8) | 0.97 | 0.9 | 0.39-2.06 |
| C \ T | 12 (8.5) | 13 (9.2) | 1.1 | 0.48-2.50 | |
| T \ T | 0 | 0 | 1 | 0.02-51.1 | |
| Allele | |||||
| C | 272 (95.7) | 269 ( 95.3) | 0.82 | 0.9 | 0.41-2.03 |
| T | 12 (4.3) | 13 (4.7) | 1.1 | 0.49-2.44 | |
- Citation: Mahmoud IS, Homsi A, Al-Ameer HJ, Alzyoud J, Darras M, Shhab MA, Zihlif M, Hatmal MM, Alshaer W. Screening the RFX6-DNA binding domain for potential genetic variants in patients with type 2 diabetes. World J Diabetes 2019; 10(3): 181-188
- URL: https://www.wjgnet.com/1948-9358/full/v10/i3/181.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i3.181